Unknown

Dataset Information

0

Current status of therapeutic monoclonal antibodies against SARS-CoV-2.

ABSTRACT:

SUBMITTER: Kumar S 

PROVIDER: S-EPMC8415613 | biostudies-literature |

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Monoclonal Antibodies against SARS-CoV-2: Current Scenario and Future Perspectives.
| S-EPMC8707981 | biostudies-literature
Unknown Structures and therapeutic potential of anti-RBD human monoclonal antibodies against SARS-CoV-2.
| S-EPMC8690919 | biostudies-literature
Unknown Novel Monoclonal Antibodies and Recombined Antibodies Against Variant SARS-CoV-2.
| S-EPMC8442604 | biostudies-literature
Unknown Receptor-binding domain-specific human neutralizing monoclonal antibodies against SARS-CoV and SARS-CoV-2.
| S-EPMC7506210 | biostudies-literature
Unknown The neutralization potency of anti-SARS-CoV-2 therapeutic human monoclonal antibodies is retained against viral variants.
| S-EPMC8379094 | biostudies-literature
Genomics Potent neutralizing antibodies against SARS-CoV-2
| EGAS00001004412 | EGA
Unknown Repurposing current therapeutic regimens against SARS-CoV-2 (Review).
| S-EPMC7401312 | biostudies-literature
Unknown Monoclonal Antibodies against SARS-CoV-2: Potential Game-Changer Still Underused.
| S-EPMC8583134 | biostudies-literature
Unknown Identification of Novel Neutralizing Monoclonal Antibodies against SARS-CoV-2 Spike Glycoprotein.
| S-EPMC8353887 | biostudies-literature
Unknown Current Potential Therapeutic Approaches against SARS-CoV-2: A Review.
| S-EPMC8615922 | biostudies-literature